Evidence map›Paper›PMID 38087182›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2024

Reduced PATL2 Impairs the Proliferation of Ovarian Granulosa Cells by Decreasing ADM2 Expression in Patients with PCOS.

Jun Tan, Pei-Pei Liu, Li-Yun Cao, Yang Zou, Zi-Yu Zhang, Jia-Lyu Huang, Zhi-Qin Zhang, Ding-Fei Xu, Lu Fan, Lei-Zhen Xia and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Compound heterozygous variants inFrontiers in medicine · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jun Tan *Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China. tanjun561127@163.com.ORCID 0000-0001-9080-7534
Pei-Pei Liu *Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Li-Yun Cao *Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Yang ZouJXHC Key Laboratory of Fertility Preservation, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Zi-Yu ZhangKey Laboratory of Women's Reproductive Health of Jiangxi Province, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Jia-Lyu HuangReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Zhi-Qin ZhangReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Ding-Fei XuReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Lu FanReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Lei-Zhen XiaReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Qi XieReproductive Medicine Center, Xinyu Maternal and Child Health Care Hospital, Xinyu, Jiangxi Province, China.
Li-Feng TianReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Cai-Lin XinReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Zeng-Ming LiJXHC Key Laboratory of Fertility Preservation, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Qiong-Fang WuReproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China.
Jiangxi Maternal and Child Health Hospital · CN

Funding

National Natural Science Foundation of China 81960271National Natural Science Foundation of China 81960288Science Fund for Distinguished Young Scholars of Jiangxi Province 20224ACB216005The General Program of Science and Technology Department of Jiangxi Province 20232BAB206029The Major Research and Development Project of Science and Technology Department of Jiangxi Province 20203BBGL73135The Major Research and Development Project of Science and Technology Department of Jiangxi Province 20203BBGL73140The Youth Fund Program of Science and Technology Department of Jiangxi Province 20232BAB216024
6 · The paper itself

Abstract

It is recognized that PCOS patients are often accompanied with aberrant follicular development, which is an important factor leading to infertility in patients. However, the relevant regulatory mechanisms of abnormal follicular development are not well understood. In the present study, by collecting human ovarian granulosa cells (GCs) from PCOS patients who underwent in vitro fertilization (IVF), we found that the proliferation ability of GCs in PCOS patients was significantly reduced. Surprisingly, PATL2 and adrenomedullin 2 (ADM2) were obviously decreased in the GCs of PCOS patients. To further explore the potential roles of PATL2 and ADM2 on GC, we transfected PATL2 siRNA into KGN cells to knock down the expression of PATL2. The results showed that the growth of GCs remarkably repressed after knocking down the PATL2, and ADM2 expression was also weakened. Subsequently, to study the relationship between PATL2 and ADM2, we constructed PATL2 mutant plasmid lacking the PAT construct and transfected it into KGN cells. The cells showed the normal PATL2 expression, but attenuated ADM2 expression and impaired proliferative ability of GCs. Finally, the rat PCOS model experiments further confirmed our findings in KGN cells. In conclusion, our study suggests that PATL2 promoted the proliferation of ovarian GCs by stabilizing the expression of ADM2 through "PAT" structure, which is beneficial to follicular development, whereas, in the ovary with polycystic lesions, reduction of PATL2 could result in the decreased expression of ADM2, subsequently weakened the proliferation ability of GCs and finally led to the occurrence of aberrant follicles.

Indexed as

Peptide HormonesPolycystic Ovary SyndromeAnimalsCell ProliferationFemaleGranulosa CellsHumansNuclear ProteinsRatsRNA-Binding ProteinsADM2 protein, humanNuclear ProteinsPATL2 protein, humanPeptide HormonesRNA-Binding ProteinsADM2Granulosa cellsPATL2PCOSProliferation ability

Identifiers

PMID38087182
OpenAlexW4389627322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.